100 related articles for article (PubMed ID: 2752813)
1. Nuclear DNA content by cytofluorometry of stage I adenocarcinoma of the lung in relation to postoperative recurrence.
Asamura H; Nakajima T; Mukai K; Shimosato Y
Chest; 1989 Aug; 96(2):312-8. PubMed ID: 2752813
[TBL] [Abstract][Full Text] [Related]
2. DNA cytofluorometric and nuclear morphometric analyses of lung adenocarcinoma.
Asamura H; Nakajima T; Mukai K; Noguchi M; Shimosato Y
Cancer; 1989 Oct; 64(8):1657-64. PubMed ID: 2790679
[TBL] [Abstract][Full Text] [Related]
3. Histopathologic prognostic factors in resected adenocarcinomas: is nuclear DNA content prognostic?
Asamura H; Ando M; Matsuno Y; Shimosato Y
Chest; 1999 Apr; 115(4):1018-24. PubMed ID: 10208203
[TBL] [Abstract][Full Text] [Related]
4. Tumor cell heterogeneity and subpopulations with metastatic ability in differentiated adenocarcinoma of the lung. Histologic and cytofluorometric DNA analyses.
Nomori H; Hirohashi S; Noguchi M; Matsuno Y; Shimosato Y
Chest; 1991 Apr; 99(4):934-40. PubMed ID: 2009798
[TBL] [Abstract][Full Text] [Related]
5. Clonal growth of atypical adenomatous hyperplasia of the lung: cytofluorometric analysis of nuclear DNA content.
Nakayama H; Noguchi M; Tsuchiya R; Kodama T; Shimosato Y
Mod Pathol; 1990 May; 3(3):314-20. PubMed ID: 2362938
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and therapeutic significance of the flow cytometric nuclear DNA content in non-small cell lung cancer.
Isobe H; Miyamoto H; Shimizu T; Haneda H; Hashimoto M; Inoue K; Mizuno S; Kawakami Y
Cancer; 1990 Mar; 65(6):1391-5. PubMed ID: 2155055
[TBL] [Abstract][Full Text] [Related]
7. The effect of tumor size and tumor cell DNA content on the survival of patients with stage I adenocarcinoma of the lung.
Cibas ES; Melamed MR; Zaman MB; Kimmel M
Cancer; 1989 Apr; 63(8):1552-6. PubMed ID: 2924263
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence cytophotometric measurements of nuclear DNA in adenocarcinoma of the lung; relation of proliferative activity and DNA ploidy to prognosis.
Blöndal T; Lindgren A
Anal Quant Cytol; 1982 Sep; 4(3):225-32. PubMed ID: 7149488
[TBL] [Abstract][Full Text] [Related]
9. Prognostic implications of DNA histogram, DNA content, and histologic changes of regional lymph nodes in patients with lung cancer.
Ogawa J; Iwazaki M; Tsurumi T; Inoue H; Shohtsu A
Cancer; 1991 Mar; 67(5):1370-6. PubMed ID: 1991300
[TBL] [Abstract][Full Text] [Related]
10. DNA content and its relationship with pathology and prognosis of colorectal carcinoma.
Jiang B; Liu CG; Wang MW; Zhao DH; Li Y; Ji XL
Chin Med J (Engl); 1992 Mar; 105(3):241-6. PubMed ID: 1395845
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic significance of the nuclear DNA content of a small adenocarcinoma of the lung].
Isobe H; Shimizu T; Miyamoto H; Kawakami Y; Okayasu K; Hashimoto M; Shimizu M; Endo T; Inoue K; Mizuno S
Gan No Rinsho; 1988 Oct; 34(12):1667-71. PubMed ID: 3193611
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of nuclear DNA content and expression of the ras oncogene product in lung cancer.
Miyamoto H; Harada M; Isobe H; Akita HD; Haneda H; Yamaguchi E; Kuzumaki N; Kawakami Y
Cancer Res; 1991 Dec; 51(23 Pt 1):6346-50. PubMed ID: 1657384
[TBL] [Abstract][Full Text] [Related]
13. [An analysis of nuclear DNA histogram of adenocarcinoma of the uterine cervix].
Yoshida K
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jun; 41(6):723-8. PubMed ID: 2768967
[TBL] [Abstract][Full Text] [Related]
14. Adenocarcinoma of the lung with selective metastasis to the lung: clinical, histologic and DNA-cytofluorometric analyses.
Nomori H; Matsuno Y; Noguchi M; Tsugane S; Shimosato Y; Hirohashi S
Jpn J Cancer Res; 1992 Jan; 83(1):93-100. PubMed ID: 1544877
[TBL] [Abstract][Full Text] [Related]
15. Nuclear DNA content as a prognostic predictor in carcinoma of the pancreas.
Yoshimura T; Manabe T; Suwa H; Imamura T; Wang Z; Ohshio G; Yamabe H; Matsumoto M; Ogasahara K; Takasan H
Int J Pancreatol; 1993 Aug; 14(1):29-36. PubMed ID: 8409574
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of tumor proliferative fraction and DNA content in stage I non-small cell lung cancer.
Filderman AE; Silvestri GA; Gatsonis C; Luthringer DJ; Honig J; Flynn SD
Am Rev Respir Dis; 1992 Sep; 146(3):707-10. PubMed ID: 1325749
[TBL] [Abstract][Full Text] [Related]
17. [Flow cytometric analysis of the DNA content of resected non-small cell lung cancer with reference to long-term follow-up].
Nagai S; Chiba W; Ikeda S; Matsumoto H; Fujimoto T; Ishida H; Wazawa H; Hanawa T; Yamashita N; Yasuda Y; Matsubara Y; Hatakenaka R; Funatsu T
Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():130-4. PubMed ID: 8678555
[TBL] [Abstract][Full Text] [Related]
18. DNA flow cytometric analysis in patients with operable non-small cell lung carcinoma.
Granone P; Cardillo G; Rumi E; D'Ugo D; Rumi C; Ciletti S; Margaritora S; Terribile D; Picciocchi A
Eur J Cardiothorac Surg; 1993; 7(7):351-5. PubMed ID: 8396951
[TBL] [Abstract][Full Text] [Related]
19. Comparison of nuclear DNA content in primary and metastatic differentiated thyroid carcinoma.
Joensuu H; Klemi PJ
Am J Clin Pathol; 1988 Jan; 89(1):35-40. PubMed ID: 3337050
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric DNA analysis of poorly differentiated adenocarcinoma of the colorectum.
Taniyama K; Suzuki H; Matsumoto M; Hakamada K; Toyama K; Tahara E
Jpn J Clin Oncol; 1991 Dec; 21(6):406-11. PubMed ID: 1805045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
